11/06/2024 | Press release | Distributed by Public on 11/06/2024 06:39
September 30, 2024 |
December 31, 2023 |
|||
ASSETS | ||||
Current assets: | ||||
Cash and cash equivalents | $ | 181,851 | $ | 253,339 |
Restricted cash | 2,202 | 22,403 | ||
Prepaid assets | 2,838 | 2,168 | ||
Other current assets | 12,583 | 34,044 | ||
Total current assets | 199,474 | 311,954 | ||
Property and equipment, net | 368,342 | 366,357 | ||
Intangible assets, net | 2,700 | 2,813 | ||
Long-term investments | 21,819 | 22,303 | ||
Right-of-use asset under operating leases | 22,640 | 24,476 | ||
Other long-term assets | 10 | 4,282 | ||
Total assets | $ | 614,985 | $ | 732,185 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||
Current liabilities: | ||||
Accounts payable | $ | 10,080 | $ | 18,113 |
Accrued liabilities and other | 21,254 | 30,790 | ||
Share-based compensation liability | 19 | 281 | ||
Total current liabilities | 31,353 | 49,184 | ||
Warrant liability | 721 | 2,025 | ||
Operating lease liability | 16,775 | 18,816 | ||
Other long-term liabilities | 27,446 | 27,444 | ||
Total liabilities | 76,295 | 97,469 | ||
Commitments and contingencies | ||||
Stockholders' equity: | ||||
Preferred stock, $0.01 par value, 10,000 shares authorized, none issued and outstanding as of both September 30, 2024 and December 31, 2023
|
- | - | ||
Common stock, $0.01 par value, 355,000 shares authorized as of both September 30, 2024 and December 31, 2023; 140,490 issued and outstanding as of September 30, 2024; and 139,705 issued and outstanding as of December 31, 2023
|
1,405 | 1,397 | ||
Additional paid-in capital | 929,324 | 925,623 | ||
Accumulated other comprehensive loss | (34,035) | (18,826) | ||
Accumulated deficit | (358,004) | (274,999) | ||
Total stockholders' equity | 538,690 | 633,195 | ||
Non-controlling interests | - | 1,521 | ||
Total equity | 538,690 | 634,716 | ||
Total liabilities and equity | $ | 614,985 | $ | 732,185 |
Three months ended September 30, |
Nine months ended September 30, |
|||||||
2024 | 2023 | 2024 | 2023 | |||||
Operating expenses: | ||||||||
General and administrative | $ | 18,515 | $ | 27,772 | $ | 61,386 | $ | 85,405 |
Research and development | 8,616 | 7,086 | 30,854 | 18,295 | ||||
Restructuring charge | 4,507 | - | 4,644 | - | ||||
Share of net loss of equity method investee | 150 | 153 | 484 | 208 | ||||
Total operating expenses | 31,788 | 35,011 | 97,368 | 103,908 | ||||
Loss from operations | (31,788) | (35,011) | (97,368) | (103,908) | ||||
Other income (expense): | ||||||||
Warrant liability fair value adjustment | 1,096 | 24,399 | 1,294 | 23,248 | ||||
Interest income, net | 1,074 | 1,284 | 3,627 | 6,042 | ||||
Foreign currency transaction (loss) gain | (110) | (3,213) | 1,245 | 20,546 | ||||
Other income, net | 2,172 | 2,537 | 7,806 | 6,103 | ||||
Total other income | 4,232 | 25,007 | 13,972 | 55,939 | ||||
Loss before income taxes | (27,556) | (10,004) | (83,396) | (47,969) | ||||
Income tax expense | - | - | (11) | (341) | ||||
Net loss | (27,556) | (10,004) | (83,407) | (48,310) | ||||
Net loss attributable to non-controlling interests | 81 | 219 | 402 | 517 | ||||
Net loss attributable to stockholders | $ | (27,475) | $ | (9,785) | $ | (83,005) | $ | (47,793) |
Weighted average shares outstanding - basic and diluted | 140,490 | 139,705 | 140,102 | 139,705 | ||||
Net loss per share attributable to stockholders - basic and diluted | $ | (0.20) | $ | (0.07) | $ | (0.59) | $ | (0.34) |
Other comprehensive (loss) income: | ||||||||
Net loss | $ | (27,556) | $ | (10,004) | $ | (83,407) | $ | (48,310) |
Foreign currency translation adjustments | 5,973 | 6,134 | (15,209) | (48,009) | ||||
Total comprehensive loss | $ | (21,583) | $ | (3,870) | $ | (98,616) | $ | (96,319) |
Comprehensive loss attributable to non-controlling interests | 81 | 219 | 402 | 517 | ||||
Comprehensive loss attributable to stockholders | $ | (21,502) | $ | (3,651) | $ | (98,214) | $ | (95,802) |
Nine months ended September 30, |
||||
2024 | 2023 | |||
Cash flows from operating activities: | ||||
Net loss | $ | (83,407) | $ | (48,310) |
Adjustments to reconcile net loss to cash used in operating activities: | ||||
Share-based compensation expense | 6,449 | 7,859 | ||
Depreciation and amortization | 7,028 | 1,922 | ||
Reduction in the carrying amount of right-of-use assets | 1,282 | 1,005 | ||
Warrant liability fair value adjustment | (1,294) | (23,248) | ||
Share of net loss of equity method investee | 484 | 208 | ||
Foreign currency transaction net unrealized gain | (1,075) | (19,346) | ||
Other | - | (929) | ||
Changes in assets and liabilities: | ||||
Prepaid assets and other current assets | 13 | 1,672 | ||
Accounts payable, accrued liabilities and other | (429) | 28,401 | ||
Operating lease liability | (1,626) | (3,212) | ||
Net cash used in operating activities | (72,575) | (53,978) | ||
Cash flows from investing activities: | ||||
Proceeds from the return of property and equipment deposits | 22,735 | - | ||
Proceeds from property related grants | - | 3,500 | ||
Purchases of property and equipment | (34,683) | (168,811) | ||
Investments in equity method investee | - | (1,655) | ||
Purchases of other long-term assets | - | (1,000) | ||
Net cash used in investing activities | (11,948) | (167,966) | ||
Cash flows from financing activities: | ||||
Payment for non-controlling interest | (4,130) | - | ||
Net cash used in financing activities | (4,130) | - | ||
Effect of changes in foreign exchange rates on cash, cash equivalents, and restricted cash | (3,036) | (13,240) | ||
Net decrease in cash, cash equivalents, and restricted cash | (91,689) | (235,184) | ||
Cash, cash equivalents, and restricted cash at beginning of period | 275,742 | 563,045 | ||
Cash, cash equivalents, and restricted cash at end of period | $ | 184,053 | $ | 327,861 |
Supplementary disclosure for non-cash activities: | ||||
Accrued purchases of property and equipment | $ | 6,133 | $ | 11,187 |
Reconciliation to condensed consolidated balance sheets: | ||||
Cash and cash equivalents | $ | 181,851 | $ | 299,419 |
Restricted cash | 2,202 | 28,442 | ||
Cash, cash equivalents, and restricted cash | $ | 184,053 | $ | 327,861 |